Using biomaterials to enhance immune responses for cancer vaccines
Biomaterials-based metabolic rescue of dendritic cells for vaccine design
This study is exploring new materials that could help boost the immune system's ability to fight cancer by making immune cells work better, even when their function is blocked, and it's aimed at improving cancer vaccines for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-11044194 on NIH RePORTER |
What this research studies
This research focuses on developing innovative biomaterial-based technologies that can enhance the function of dendritic cells and T-cells, which are crucial for initiating immune responses against tumors. By using polymeric particles made from central-carbon metabolites, the study aims to restore metabolic functions in these immune cells even when metabolic inhibitors are present. The approach involves testing these biomaterials in animal models to see if they can effectively stimulate long-lasting immune responses and improve the efficacy of cancer vaccines.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with cancer who are seeking innovative immunotherapy options.
Not a fit: Patients with non-cancerous conditions or those who are not eligible for immunotherapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer vaccines that enhance the body's immune response against tumors.
How similar studies have performed: Other research has shown promise in using biomaterials to enhance immune responses, suggesting that this approach could be a viable strategy for improving cancer immunotherapy.
Where this research is happening
Cleveland, United States
- Case Western Reserve University — Cleveland, United States (Active)
Researchers
- Principal investigator: Acharya, Abhinav — Case Western Reserve University
- Study coordinator: Acharya, Abhinav
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.